A patient information leaflet is a technical document included in every medicine package to offer written information about the medication. Patient information leaflets (PILs) are provided by the ...

Lots of information on the side effects of medicines are making people anxious, the report says There is too much focus on the potential side-effects of medicines on information leaflets inside packs ...

A survey of thousands of people in England suggests it may be time to look again at how pharma manufacturers are delivering product information to patients. The poll found that out of almost 3,000 ...

Depending on your pharmacy for information on the side effects and potentially deadly interactions of prescription medications could be putting your life in jeopardy. More than 10,000 Americans die ...

Ever wondered why you see the lengthy information enclosed in a prescribed or Over The Counter (OTC) medication packaging? The enclosed document is known as the patient information leaflet (PIL). Some ...

The Commission’s proposal to digitise the leaflets comes with the addition that if they are only available electronically, “the patient’s right to a printed copy of the package leaflet should be ...

Purpose: This article explores how a “neutral” genetics information leaflet influenced people’s attitudes to be more positive toward predictive genetic testing. This is of concern, given the desire ...

The European Commission's proposed pharmaceutical strategy leaves it to the countries to decide whether the medicine information leaflet is in paper format electronic, or both. However, moving ...

Background The purpose of patient information leaflets (PILs) is to inform patients about the administration, precautions and potential side effects of their prescribed medication. Despite European ...